Veraxa Biotech Holding AG VRXA Cash Flow Statement (2025)

NASDAQ VRXA
$1.89 +0.03 (+1.61%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Dec2025
Operating Activities
Cash from Operations (Quarter) 1,251.17
Change in Working Capital
Change in Accured Expenses (Quarter) 22,521.06
Financing Activities
Cash from Financing Activities (Quarter) 125,116.98
Additional items
Change in Cash (Quarter) 126,368.15
Free Cash Flow (Quarter) 1,251.17
Net Cash Flow (Quarter) 126,368.15